• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QRS 评分作为 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后出院的强预后标志物的效用。

Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

机构信息

University of Alberta, Edmonton, Canada.

出版信息

Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.

DOI:10.1016/j.amjcard.2010.04.013
PMID:20723636
Abstract

The prognostic value of myocardial infarct size estimation by QRS scoring in patients with ST-segment elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (PCI) is unclear. The standard 32-point Selvester QRS score on the discharge electrocardiogram (each point approximately 3% left ventricular mass) was calculated in 4,113 patients with STEMI who underwent primary PCI and survived to hospital discharge in the APEX-AMI trial. QRS scores were divided into tertiles, i.e., < or =3 (<10% myocardium), 4 to 7 (10% to 21% myocardium), and > or =8 (>21% myocardium). Adjusted associations between QRS score and 90-day outcomes (death and composite of death/congestive heart failure (CHF)/shock) were examined. Higher QRS scores were associated with male gender, higher heart rate, worse Killip class, noninferior infarct location, greater ST-segment deviation, and longer times to reperfusion. Higher QRS scores were also associated with impaired culprit artery flow before and after PCI and more frequent multivessel disease. Adverse outcomes occurred more often in patients with higher QRS scores (90-day death: 1.9%, QRS score 0 to 3; 3.4%, 4 to 7; 4.9%, > or =8; 90-day death/shock/CHF: 4.5%, 0-3; 7.8%, 4 to 7; 12.1%, > or =8). After multivariable adjustment, patients with higher QRS scores remained more likely to develop an adverse outcome versus those with QRS scores < or =3 (score 4 to 7, hazard ratios [HR] for death 2.08, 95% confidence interval [CI] 1.26 to 3.41; HR for death/CHF/shock 2.00, 95% CI 1.26 to 3.17; score > or =8, HR for death 2.57, 95% CI 1.56 to 4.24, HR for death/CHF/shock 2.93, 95% CI 1.84 to 4.67). In conclusion, infarct size as estimated by QRS scoring at hospital discharge is an independent and prognostically relevant metric in patients with STEMI undergoing primary PCI.

摘要

在接受直接经皮冠状动脉介入治疗(PCI)的 ST 段抬高型心肌梗死(STEMI)患者中,通过 QRS 评分估计心肌梗死面积的预后价值尚不清楚。在 APEX-AMI 试验中,对 4113 例接受直接 PCI 并存活至出院的 STEMI 患者,在出院时的标准 32 分 Selvester QRS 评分(每点约为 3%的左心室质量)进行了计算。QRS 评分分为三分位数,即 <或=3(<10%心肌)、4 至 7(10%至 21%心肌)和 >或=8(>21%心肌)。检查了 QRS 评分与 90 天结局(死亡和死亡/充血性心力衰竭(CHF)/休克的复合)之间的调整关联。较高的 QRS 评分与男性、较高的心率、较差的 Killip 分级、非劣效性梗死部位、较大的 ST 段偏移和再灌注时间较长有关。较高的 QRS 评分也与 PCI 前后罪犯动脉血流受损以及更频繁的多血管疾病有关。较高 QRS 评分的患者不良结局更为常见(90 天死亡率:1.9%,QRS 评分 0 至 3;3.4%,4 至 7;4.9%,>或=8;90 天死亡率/休克/CHF:4.5%,0-3;7.8%,4 至 7;12.1%,>或=8)。在多变量调整后,与 QRS 评分 <或=3 的患者相比,QRS 评分较高的患者发生不良结局的可能性更高(评分 4 至 7,死亡的 HR 为 2.08,95%CI 为 1.26 至 3.41;死亡/CHF/休克的 HR 为 2.00,95%CI 为 1.26 至 3.17;评分 >或=8,死亡的 HR 为 2.57,95%CI 为 1.56 至 4.24,死亡/CHF/休克的 HR 为 2.93,95%CI 为 1.84 至 4.67)。总之,在接受直接 PCI 的 STEMI 患者中,出院时通过 QRS 评分估计的梗死面积是一个独立的、具有预后相关性的指标。

相似文献

1
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.QRS 评分作为 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后出院的强预后标志物的效用。
Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.
2
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的ST段恢复情况及预后:急性心肌梗死中佩昔单抗评估(APEX-AMI)试验的见解
Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.
3
Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.塞尔维斯特QRS评分水平可预测接受直接冠状动脉介入治疗的急性心肌梗死患者的ST段恢复情况及30天预后。
Am Heart J. 2006 Jun;151(6):1239.e1-7. doi: 10.1016/j.ahj.2006.03.019.
4
Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction.首次ST段抬高型心肌梗死后出院前QRS评分与心力衰竭风险
J Card Fail. 2008 Apr;14(3):225-31. doi: 10.1016/j.cardfail.2007.11.004.
5
Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).ST 段抬高型心肌梗死患者早期出院的安全性和可行性——低危患者行直接经皮冠状动脉介入治疗的前瞻性随机试验(Safe-Depart 试验)。
Am Heart J. 2010 Jan;159(1):117.e1-6. doi: 10.1016/j.ahj.2009.10.024.
6
Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,冠状动脉心外膜血流的目测评估是否可靠?来自 Pexelizumab 在急性心肌梗死评估(APEX-AMI)试验的血管造影亚研究的结果。
Am Heart J. 2010 May;159(5):899-904. doi: 10.1016/j.ahj.2010.02.028.
7
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".急性ST段抬高型心肌梗死(STEMI)后早期对比增强心脏磁共振成像(CMR)对区域STEMI网络的预后影响:“埃森心肌梗死联盟”的研究结果
Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.
8
Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.再灌注的血管造影和心电图参数对急性ST段抬高型心肌梗死患者死亡率和发病率预测的贡献:急性心肌梗死中佩昔单抗评估试验的见解
Am Heart J. 2009 Nov;158(5):755-60. doi: 10.1016/j.ahj.2009.09.009. Epub 2009 Oct 3.
9
Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).在接受纤溶治疗或直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死后,动态心电图监测中ST段偏移的患病率及其预后意义(丹麦急性心肌梗死试验-2子研究)
Am J Cardiol. 2007 Sep 15;100(6):937-43. doi: 10.1016/j.amjcard.2007.04.032. Epub 2007 Jul 2.
10
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).ST段抬高型心肌梗死直接经皮冠状动脉介入治疗期间非梗死动脉介入治疗的患病率、预测因素及院内结局(来自国家心血管数据注册库)
Am J Cardiol. 2009 Aug 15;104(4):507-13. doi: 10.1016/j.amjcard.2009.04.016. Epub 2009 Jun 18.

引用本文的文献

1
Simple indices of infarct size post ST-Elevation Myocardial Infarction (STEMI) provides similar risk stratification to cardiac MRI.ST 段抬高型心肌梗死(STEMI)后梗死面积的简单指标与心脏 MRI 提供相似的风险分层。
PLoS One. 2024 Nov 21;19(11):e0311157. doi: 10.1371/journal.pone.0311157. eCollection 2024.
2
Relationship between Selvester ECG Score and Cardiovascular Outcomes in Patients with Non-ST Elevation Myocardial Infarction.非ST段抬高型心肌梗死患者塞尔维斯特心电图评分与心血管结局的关系
Acta Cardiol Sin. 2021 Nov;37(6):580-590. doi: 10.6515/ACS.202111_37(6).20210602A.
3
Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy.
塞尔维斯特评分可预测非缺血性心肌病患者植入式心律转复除颤器的电击次数。
J Arrhythm. 2021 Jun 7;37(4):1046-1051. doi: 10.1002/joa3.12571. eCollection 2021 Aug.
4
In Comparison to Pathological Q Waves, Selvester Score is a Superior Diagnostic Indicator of Increased Long-Term Mortality Risk in ST Elevation Myocardial Infarction Patients Treated with Primary Coronary Intervention.与病理性Q波相比,塞尔维斯特评分是接受直接冠状动脉介入治疗的ST段抬高型心肌梗死患者长期死亡风险增加的更优诊断指标。
Diagnostics (Basel). 2021 Apr 28;11(5):799. doi: 10.3390/diagnostics11050799.
5
Both baseline Selvester QRS score and change in QRS score predict prognosis in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention.基线 Selvester QRS 评分和 QRS 评分变化均能预测经皮冠状动脉介入治疗后急性 ST 段抬高型心肌梗死患者的预后。
Coron Artery Dis. 2020 Aug;31(5):403-410. doi: 10.1097/MCA.0000000000000869.
6
Complete versus simplified Selvester QRS score for infarct severity assessment in ST-elevation myocardial infarction.完整与简化 Selvester QRS 评分在 ST 段抬高型心肌梗死中的梗死严重程度评估。
BMC Cardiovasc Disord. 2019 Dec 9;19(1):285. doi: 10.1186/s12872-019-1230-0.
7
Differences in the Selvester QRS score after primary PCI strategy and conservative treatment for STEMI patients with negative T waves.ST段抬高型心肌梗死(STEMI)伴T波阴性患者采用直接经皮冠状动脉介入治疗(PCI)策略与保守治疗后塞尔维斯特QRS评分的差异。
Ann Noninvasive Electrocardiol. 2019 Nov;24(6):e12684. doi: 10.1111/anec.12684. Epub 2019 Aug 1.
8
PPARα activation alleviates damage to the cytoskeleton during acute myocardial ischemia/reperfusion in rats.过氧化物酶体增殖物激活受体 α 的激活减轻了大鼠急性心肌缺血/再灌注过程中的细胞骨架损伤。
Mol Med Rep. 2018 May;17(5):7218-7226. doi: 10.3892/mmr.2018.8771. Epub 2018 Mar 16.
9
QRS duration predicts 30 day mortality following ST elevation myocardial infarction.QRS波时限可预测ST段抬高型心肌梗死患者30天死亡率。
Int J Cardiol Heart Vasc. 2014 Nov 7;5:42-44. doi: 10.1016/j.ijcha.2014.10.010. eCollection 2014 Dec.
10
Screening for Cardiac Magnetic Resonance Scar Features by 12-Lead ECG, in Patients with Preserved Ejection Fraction.利用12导联心电图对射血分数保留的患者进行心脏磁共振疤痕特征筛查。
Ann Noninvasive Electrocardiol. 2016 Jan;21(1):49-59. doi: 10.1111/anec.12264.